FBP1 and neoplasm: We found that 47.2% (n = 177) of the tumor tissues exhibited high-FBP1 immunostaining (defined as moderate or strong), and 52.8% (n = 198) exhibited low-FBP1 immunostaining (defined as negative or weak) (Fig. 1B, C).